Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Current Deferred Revenue (2016 - 2025)

Dolby Laboratories (DLB) has disclosed Current Deferred Revenue for 17 consecutive years, with $37.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue changed N/A year-over-year to $37.1 million, compared with a TTM value of $37.1 million through Dec 2025, changed N/A, and an annual FY2025 reading of $31.4 million, down 0.83% over the prior year.
  • Current Deferred Revenue was $37.1 million for Q4 2025 at Dolby Laboratories, up from $31.4 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $37.7 million in Q1 2024 and bottomed at $18.5 million in Q3 2021.
  • Average Current Deferred Revenue over 5 years is $27.1 million, with a median of $26.9 million recorded in 2022.
  • The sharpest move saw Current Deferred Revenue surged 69.49% in 2023, then dropped 0.83% in 2025.
  • Year by year, Current Deferred Revenue stood at $18.5 million in 2021, then grew by 21.02% to $22.4 million in 2022, then surged by 40.92% to $31.5 million in 2023, then increased by 0.44% to $31.6 million in 2024, then grew by 17.22% to $37.1 million in 2025.
  • Business Quant data shows Current Deferred Revenue for DLB at $37.1 million in Q4 2025, $31.4 million in Q3 2025, and $31.6 million in Q3 2024.